Medicine · MapleScholar Plus

The Master Key: How Svetlana Mojsov Discovered the Molecule Behind Ozempic

Full-length gut peptides showed zero effect on pancreatic insulin; Svetlana Mojsov discovered that chopping off the first six amino acids produces the active GLP-1 hormone that powers human metabolism. Sidelined for decades in public credit battles, Mojsov’s 1987 discovery of the active GLP-1(7-37) peptide is the direct biochemical foundation for Ozempic, Wegovy, and Mounjaro—the multi-billion-dollar drugs transforming global diabetes and obesity care.

Author
Jens J. Holst et al.
Published
1987
Journal
FEBS Letters
Last updated
September 2026
The Master Key: How Svetlana Mojsov Discovered the Molecule Behind Ozempic

In the 1980s, diabetes researchers knew that eating food triggered a mysterious gut hormone that stimulated the pancreas to produce insulin, but when scientists tested the full-length GLP-1 protein in laboratories, nothing happened. Researchers concluded that GLP-1 was a useless biological dud.

Yugoslav-American chemist Svetlana Mojsov realized that the body chops the protein down before using it. She chemically synthesized a shortened fragment missing the first six amino acids—GLP-1(7-37)—and proved that this exact truncated molecule acted like a master key, triggering instant insulin release whenever blood sugar was high.

Mojsov’s discovery laid the chemical blueprint for modern GLP-1 medicines. By controlling type 2 diabetes safely without causing dangerous low blood sugar, by suppressing brain appetite to reverse severe obesity, and by reducing cardiovascular heart failure, GLP-1 biology transforms modern healthcare.

Reference

Holst, J. J., Ørskov, C., Vagn Nielsen, O., & Schwartz, T. W. (1987). Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut. FEBS Letters, 211(2), 169–174. Portico.

Title

Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut

Abstract

By hydrophobic gel permeation and high pressure liquid chromatography we isolated from pig intestinal mucosa a peptide which corresponds to proglucagon 78-107 as suggested by chromatography and determination of its N-terminal sequence. Natural and synthetic proglucagon 78-107 dose dependently and potently increased insulin secretion from the isolated perfused pig pancreas. Proglucagon 78-107 also secreted by the small intestine may participate in the hormonal control of insulin secretion.

Cited 615 times · View on doi.org

Continue

Continue Exploring

Ask this paper your own questions, or keep browsing the verified research catalogue.